home / stock / lgnd / lgnd articles

LGND Articles, Ligand Pharmaceuticals Incorporated - From 03/28/24

Stock Information
Company Name: Ligand Pharmaceuticals Incorporated
Stock Symbol: LGND
Market: NASDAQ
Website: ligand.com
Menu
LGND LGND Quote LGND Short LGND News LGND Articles LGND Message Board
Get LGND Alerts

News, Short Squeeze, Breakout and More Instantly...
At Ligand Pharmaceuticals, Todd C Davis Chooses To Exercise Options, Resulting In $252K | Benzinga

A significant insider transaction involving the exercise of company stock options was reported on March 27, by Todd C Davis, Chief Executive Office...
Why Is Ligand Pharmaceuticals Stock Trading Higher Today? | Benzinga

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) reported fourth-quarter 2023 sales of $28.1 million, beating the consensus of $25.72 mi...

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Helix Energy posted ...

Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday. Shares of Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) ...
Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's | Benzinga

Merck & Co Inc (NYSE: MRK) released results from the STRIDE-3 Phase 3 trial evaluating V116, the company's investigational 21-valent&n...

Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Breast Cancer Symposium | Benzinga

COLUMBUS, Ohio, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovativ...

Ligand Pharmaceuticals Chief Executive Officer Trades $237K In Company Stock | Benzinga

Todd C Davis, Chief Executive Officer at Ligand Pharmaceuticals (NASDAQ:LGND), reported a large insider buy on September 25, according to a new SEC...
Ligand Pharma Updates Annual Guidance As It Spins Out Pelican Subsidiary | Benzinga

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) entered into a merger agreement under which its subsidiary, Pelican Technology Holding...

Previous 10 Next 10